A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Spectrum Disorder
Clinical trial NCT04049578 · TERMINATED
Trial details
- NCT number
- NCT04049578
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-19
- Primary completion
- 2020-04-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.